245 related articles for article (PubMed ID: 16938654)
1. Biological features (inflammation and neoangiogenesis) and atherosclerotic risk factors in carotid plaques and calcified aortic valve stenosis: two different sites of the same disease?
Mazzone A; Epistolato MC; Gianetti J; Castagnini M; Sassi C; Ceravolo R; Bevilacqua S; Glauber M; Biagini A; Tanganelli P
Am J Clin Pathol; 2006 Oct; 126(4):494-502. PubMed ID: 16938654
[TBL] [Abstract][Full Text] [Related]
2. Neoangiogenesis, T-lymphocyte infiltration, and heat shock protein-60 are biological hallmarks of an immunomediated inflammatory process in end-stage calcified aortic valve stenosis.
Mazzone A; Epistolato MC; De Caterina R; Storti S; Vittorini S; Sbrana S; Gianetti J; Bevilacqua S; Glauber M; Biagini A; Tanganelli P
J Am Coll Cardiol; 2004 May; 43(9):1670-6. PubMed ID: 15120829
[TBL] [Abstract][Full Text] [Related]
3. VAP-1, Eotaxin3 and MIG as potential atherosclerotic triggers of severe calcified and stenotic human aortic valves: effects of statins.
Anger T; Pohle FK; Kandler L; Barthel T; Ensminger SM; Fischlein T; Weyand M; Stumpf C; Daniel WG; Garlichs CD
Exp Mol Pathol; 2007 Dec; 83(3):435-42. PubMed ID: 17490641
[TBL] [Abstract][Full Text] [Related]
4. Bone regulatory factors NFATc1 and Osterix in human calcific aortic valves.
Alexopoulos A; Bravou V; Peroukides S; Kaklamanis L; Varakis J; Alexopoulos D; Papadaki H
Int J Cardiol; 2010 Mar; 139(2):142-9. PubMed ID: 19019468
[TBL] [Abstract][Full Text] [Related]
5. Atherosclerotic inflammation triggers osteogenic bone transformation in calcified and stenotic human aortic valves: still a matter of debate.
Anger T; Carson W; Weyand M; Daniel WG; Hoeher M; Garlichs CD
Exp Mol Pathol; 2009 Feb; 86(1):10-7. PubMed ID: 19084515
[TBL] [Abstract][Full Text] [Related]
6. [Expression and significance of inflammatory factors and bone formation mediators in carotid atherosclerotic plaque].
Zheng W; Kang H; Shu C; Tang ML; Fang PZ; Xie J; He J; Wang M
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Aug; 33(8):746-50. PubMed ID: 18772518
[TBL] [Abstract][Full Text] [Related]
7. Calcific aortic valve stenosis: Immunohistochemical analysis of inflammatory infiltrate.
Steiner I; Krbal L; Rozkoš T; Harrer J; Laco J
Pathol Res Pract; 2012 Apr; 208(4):231-4. PubMed ID: 22436689
[TBL] [Abstract][Full Text] [Related]
8. Density of Chlamydia pneumoniae is increased in fibrotic and calcified areas of degenerative aortic stenosis.
Pierri H; Higuchi-dos-Santos MH; Higuchi Mde L; Palomino S; Sambiase NV; Demarchi LM; Rodrigues GH; Nussbacher A; Ramires JA; Wajngarten M
Int J Cardiol; 2006 Mar; 108(1):43-7. PubMed ID: 15925417
[TBL] [Abstract][Full Text] [Related]
9. Molecular and cellular mechanisms of aortic stenosis.
Yetkin E; Waltenberger J
Int J Cardiol; 2009 Jun; 135(1):4-13. PubMed ID: 19386374
[TBL] [Abstract][Full Text] [Related]
10. Calcific aortic valve disease and aortic atherosclerosis--two faces of the same disease?
Ginghină C; Florian A; Beladan C; Iancu M; Călin A; Popescu BA; Jurcuţ R
Rom J Intern Med; 2009; 47(4):319-29. PubMed ID: 21179913
[TBL] [Abstract][Full Text] [Related]
11. Aortic valve stenosis and coronary artery disease: pathophysiological and clinical links.
Mazzone A; Venneri L; Berti S
J Cardiovasc Med (Hagerstown); 2007 Dec; 8(12):983-9. PubMed ID: 18163008
[TBL] [Abstract][Full Text] [Related]
12. Role of inflammation in nonrheumatic, regurgitant heart valve disease. A comparative, descriptive study regarding apolipoproteins and inflammatory cells in nonrheumatic heart valve disease.
Wallby L; Steffensen T; Broqvist M
Cardiovasc Pathol; 2007; 16(3):171-8. PubMed ID: 17502247
[TBL] [Abstract][Full Text] [Related]
13. Systemic and local levels of fetuin-A in calcific aortic valve stenosis.
Kaden JJ; Reinöhl JO; Blesch B; Brueckmann M; Haghi D; Borggrefe M; Schmitz F; Klomfass S; Pillich M; Ortlepp JR
Int J Mol Med; 2007 Aug; 20(2):193-7. PubMed ID: 17611637
[TBL] [Abstract][Full Text] [Related]
14. Mitral and aortic annular calcification are highly associated with systemic calcified atherosclerosis.
Allison MA; Cheung P; Criqui MH; Langer RD; Wright CM
Circulation; 2006 Feb; 113(6):861-6. PubMed ID: 16461818
[TBL] [Abstract][Full Text] [Related]
15. Common pathogenic features of atherosclerosis and calcific aortic stenosis: role of transforming growth factor-beta.
Xu S; Liu AC; Gotlieb AI
Cardiovasc Pathol; 2010; 19(4):236-47. PubMed ID: 19942455
[TBL] [Abstract][Full Text] [Related]
16. In vivo aortic valve thermal heterogeneity in patients with nonrheumatic aortic valve stenosis the: first in vivo experience in humans.
Toutouzas K; Drakopoulou M; Synetos A; Tsiamis E; Agrogiannis G; Kavantzas N; Patsouris E; Iliopoulos D; Theodoropoulos S; Yacoub M; Stefanadis C
J Am Coll Cardiol; 2008 Aug; 52(9):758-63. PubMed ID: 18718425
[TBL] [Abstract][Full Text] [Related]
17. Relations of inflammation and novel risk factors to valvular calcification.
Fox CS; Guo CY; Larson MG; Vasan RS; Parise H; O'Donnell CJ; D'Agostino RB; Keaney JF; Benjamin EJ
Am J Cardiol; 2006 May; 97(10):1502-5. PubMed ID: 16679093
[TBL] [Abstract][Full Text] [Related]
18. Association between circulating oxidised low-density lipoprotein and fibrocalcific remodelling of the aortic valve in aortic stenosis.
Côté C; Pibarot P; Després JP; Mohty D; Cartier A; Arsenault BJ; Couture C; Mathieu P
Heart; 2008 Sep; 94(9):1175-80. PubMed ID: 17932090
[TBL] [Abstract][Full Text] [Related]
19. Apelin and its receptor APJ in human aortic valve stenosis.
Peltonen T; Näpänkangas J; Vuolteenaho O; Ohtonen P; Soini Y; Juvonen T; Satta J; Ruskoaho H; Taskinen P
J Heart Valve Dis; 2009 Nov; 18(6):644-52. PubMed ID: 20099713
[TBL] [Abstract][Full Text] [Related]
20. Aortic valve stenosis: an active atheroinflammatory process.
Helske S; Kupari M; Lindstedt KA; Kovanen PT
Curr Opin Lipidol; 2007 Oct; 18(5):483-91. PubMed ID: 17885417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
